Under construction – not a live service
Sign in
Taking peopleNo phase

CBT-I in Physically Active Participants With Insomnia Complaints

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 30 and 59 years old?

Source: NCT07607444, who can take part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Federal University of Jatai
Trial code
NCT07607444
Record updated
2 September 2026
Original description
The goal of this clinical trial is to learn if Cognitive Behavioral Therapy for Insomnia (CBT-I) can treat insomnia complaints in participants physically active; men and woman; aged 30-59 years old. The main question it aims to answer is:Read full original descriptionShow less

Effects of Cognitive Behavioral Therapy for Insomnia (CBT-I) in Physically Active Participants With Insomnia Complaints: a Randomized Clinical Trial

The goal of this clinical trial is to learn if Cognitive Behavioral Therapy for Insomnia (CBT-I) can treat insomnia complaints in participants physically active; men and woman; aged 30-59 years old. The main question it aims to answer is:

Can this terapy to reduce the insomnia severity? Can this terapy to improve sleep and related complaints?

Researchers will compare CBT-I vs No treatment to see if CBT-I can promote better sleep.

Participants will receive 6 weeks of treatment.

Inclusion: Age range between 30-59 years; Practice regular physical exercise for over 150 minutes per week; Complaints of insomnia (difficulty initiating and/or maintaining sleep and/or early awakening) more than three times a week, for at least three months, associated with complaints of daytime impairments (occupational, academic or social) related to insomnia; Insomnia severity index greater than fifteen (>15).

Exclusion: Evidence that insomnia is associated with medication side effects; Evidence that insomnia is associated with restless legs syndrome; Evidence that insomnia is associated with signs or symptoms of mental disorders; Shift workers; Abusive use of alcohol or illicit psychoactive substances.

ClinicalTrials.gov NCT07607444